Denali Therapeutics Inc.
DNLI | NASDAQ
$21.46
+$0.99 (+4.84%)
Sep 22, 2026, 12:43 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 205.33M | 174.96M | 127.11M | 218.04M | 293.48M | 507.14M |
Short-Term Investments | 662.55M | 657.37M | 907.41M | 1.12B | 571.93M | 962.55M |
Long-Term Investments | 98.32M | 359.37M | n/a | 1.5M | 425.45M | 34.2M |
Other Long-Term Assets | 25.94M | 24.74M | 18.14M | 11.9M | 11.87M | 962K |
Receivables | 2.18M | 2.17M | 3.42M | 9.28M | 1.23M | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 30.6M | n/a | n/a | n/a | n/a | 25.96M |
Total Current Assets | 900.66M | 864.44M | 1.06B | 1.37B | 897.23M | 1.5B |
Property-Plant & Equipment | 119.94M | 125.63M | 71.64M | 74.52M | 69.61M | 73.46M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 244.2M | 509.74M | 89.78M | 87.92M | 506.93M | 108.63M |
Total Assets | 1.14B | 1.37B | 1.15B | 1.46B | 1.4B | 1.6B |
Account Payables | 3.33M | 11.14M | 9.48M | 2.79M | 4.78M | 1.07M |
Deferred Revenue | n/a | n/a | n/a | 290.05M | 320.3M | 23.48M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 4.69M |
Other Current Liabilities | 53.28M | 38.86M | 21.59M | 17.09M | 19.01M | 21.95M |
Total Current Liabilities | 98.35M | 102.21M | 77.98M | 363.92M | 378.25M | 71.7M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 5.53M | 5.62M | n/a | 379K | 379K | 701K |
Total Long-Term Liabilities | 32.74M | 42.29M | 44.98M | 53.89M | 63.63M | 382.05M |
Total Liabilities | 131.09M | 144.5M | 122.96M | 417.81M | 441.87M | 453.75M |
Total Debt | 36.76M | 48.71M | 52.24M | 60.35M | 64.01M | 68.87M |
Book Value | 1.01B | 1.23B | 1.03B | 1.04B | 962.29M | 1.15B |
Book Value Per Share | 5.78 | 7.48 | 7.50 | 8.30 | 7.92 | 10.21 |
Common Stock | 1.89M | 1.77M | 1.71M | 1.69M | 1.55M | 1.53M |
Retained Earnings | -2.05B | -1.54B | -1.12B | -970.99M | -645M | -354.42M |
Comprehensive Income | 682K | 2.02M | 643K | -6.89M | -2.5M | -245K |
Shareholders Equity | 1.01B | 1.23B | 1.03B | 1.04B | 962.29M | 1.15B |
Total Investments | 760.88M | 1.02B | 907.41M | 1.12B | 997.38M | 996.75M |
Add to Watchlist
Select watchlists to add or remove DNLI